# The Immunostimulatory Effects of Gentamicin

> **NCT05303909** · PHASE2 · TERMINATED · sponsor: **Singapore General Hospital** · enrollment: 33 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Gentamicin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05303909
- **Lead sponsor:** Singapore General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-05-11
- **Primary completion:** 2024-05-13
- **Final completion:** 2024-05-13
- **Target enrollment:** 33 (ACTUAL)
- **Why stopped:** slow recruitment due to COVID19
- **Last updated:** 2024-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05303909

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05303909, "The Immunostimulatory Effects of Gentamicin". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05303909. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*